News
More than 170 people were screened for a condition known as diabetic eye disease through a free programme offered across the ...
Researchers at Edith Cowan University (ECU) have developed a cutting-edge Artificial Intelligence (AI) system that could ...
Researchers at Edith Cowan University (ECU) have developed a cutting-edge Artificial Intelligence (AI) system that could support medical professionals in detecting and accurately diagnosing the stage ...
According to Varma, African Americans have a high rate of visual impairment and are especially likely to develop open-angle ...
Letter writers discuss Improving Seniors’ Timely Access to Care Act, attacks against President Trump, and five tenets of ...
Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...
4d
Clinical Trials Arena on MSNANI Pharmaceuticals reports outcomes from diabetic macular oedema trialThe trial subjects were adults with either type 1 or type 2 diabetes, exhibiting central involvement in diabetic macular ...
Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 ...
(HealthDay News) — An artificial intelligence (AI) model integrated into a retina tracker for diabetic retinopathy can achieve high accuracy while being resource-efficient, according to a study ...
Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...
Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...
Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results